| Group A >70 (n 27) | Group B <70 (n 81) | P value |
---|---|---|---|
1-year follow-up | n (%) | n (%) | Â |
Function | Â | Â | Â |
   Mean stool frequency per day (±SD) | 4.6 (±2.1) | 4.8 (±2.3) | NS |
   Patients with night evacuation | 7 (25.9) | 20 (24.7) | NS |
   Urgency | 2 (7.4) | 6 (7.4) | NS |
   Incontinence during day | 1 (3.7) | 2 (2.5) | NS |
   Incontinence during night | 2 (7.4) | 2 (2.5) | NS |
   Impaired discrimination | 6 (22.3) | 15 (18.5) | NS |
   Pad | 7 (25.9) | 18 (22.3) | NS |
   Antidiarrhoeals | 14 (51.9) | 23 (28.4) | 0.03 |
IBDQ | Â | Â | Â |
   Excellent/Good (>150) | 16 (59.3) | 52 (64.2) | NS |
   Regular (101-150) | 10 (37) | 27 (33.3) | NS |
   Bad (<101) | 1 (3.7) | 2 (2.5) | NS |
 | Group A* | Group B* | P |
 | >70 (n 26) | <70 (n 80) | value |
3-year follow-up | n (%) | n (%) | Â |
Function | Â | Â | Â |
Mean stool frequency per day (±SD) | 4.8 (±2.2) | 4.9 (±1.9) | NS |
Patients with night evacuation | 7 (26.9) | 21 (26.2) | NS |
Urgency | 3 (11.5) | 9 (11.2) | NS |
Incontinence during day | 1 (3.8) | 2 (2.5) | NS |
Incontinence during night | 2 (7.7) | 2 (2.5) | NS |
Impaired discrimination | 7 (26.9) | 17 (21.2) | NS |
Pad | 6 (23) | 19 (23.7) | NS |
Antidiarrhoeals | 12 (46.1) | 24 (30) | NS |
IBDQ | Â | Â | Â |
Excellent/Good (>150) | 14 (53.8) | 48 (60) | NS |
Regular (101-150) | 11 (42.3) | 30 (37.5) | NS |
Bad (<101) | 1 (3.9) | 2 (2.5) | NS |